Mark Ragosa Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Mark Ragosa is CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 26,498 shares of KNSA, which is worth approximately $548,243. The most recent transaction as insider was on Apr 07, 2025, when has been sold 1,303 shares (Class A Ordinary Share) at a price of $20.28 per share, resulting in proceeds of $26,424. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.5K
15.42% 3M change
41.16% 12M change
Total Value Held $548,243

Mark Ragosa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 07 2025
SELL
Payment of exercise price or tax liability
$26,424 $20.28 p/Share
1,303 Reduced 4.69%
26,498 Class A Ordinary Share
Apr 07 2025
BUY
Exercise of conversion of derivative security
-
2,694 Added 8.83%
27,801 Class A Ordinary Share
Apr 01 2025
SELL
Payment of exercise price or tax liability
$35,202 $21.77 p/Share
1,617 Reduced 6.05%
25,107 Class A Ordinary Share
Apr 01 2025
BUY
Exercise of conversion of derivative security
-
3,342 Added 11.12%
26,724 Class A Ordinary Share
Mar 20 2025
SELL
Open market or private sale
$368,465 $23.11 p/Share
15,944 Reduced 40.54%
23,382 Class A Ordinary Share
Mar 20 2025
BUY
Exercise of conversion of derivative security
$206,793 $12.97 p/Share
15,944 Added 28.85%
39,326 Class A Ordinary Share
Mar 19 2025
SELL
Open market or private sale
$205,104 $23.1 p/Share
8,879 Reduced 27.52%
23,382 Class A Ordinary Share
Mar 19 2025
BUY
Exercise of conversion of derivative security
$115,160 $12.97 p/Share
8,879 Added 21.58%
32,261 Class A Ordinary Share
Mar 17 2025
SELL
Open market or private sale
$264,818 $23.1 p/Share
11,464 Reduced 32.9%
23,382 Class A Ordinary Share
Mar 17 2025
BUY
Exercise of conversion of derivative security
$148,688 $12.97 p/Share
11,464 Added 24.75%
34,846 Class A Ordinary Share
Mar 16 2025
SELL
Payment of exercise price or tax liability
$10,129 $22.61 p/Share
448 Reduced 1.88%
23,382 Class A Ordinary Share
Mar 16 2025
BUY
Exercise of conversion of derivative security
-
872 Added 3.53%
23,830 Class A Ordinary Share
Mar 12 2025
SELL
Open market or private sale
$809,277 $22.25 p/Share
36,372 Reduced 61.3%
22,958 Class A Ordinary Share
Mar 12 2025
BUY
Exercise of conversion of derivative security
$435,372 $11.97 p/Share
36,372 Added 38.01%
59,330 Class A Ordinary Share
Dec 09 2024
SELL
Open market or private sale
$403,226 $21.38 p/Share
18,860 Reduced 45.1%
22,958 Class A Ordinary Share
Dec 09 2024
BUY
Exercise of conversion of derivative security
$209,346 $11.1 p/Share
18,860 Added 31.08%
41,818 Class A Ordinary Share
Dec 06 2024
SELL
Open market or private sale
$190,770 $21.27 p/Share
8,969 Reduced 28.09%
22,958 Class A Ordinary Share
Dec 06 2024
BUY
Exercise of conversion of derivative security
$25,888 $10.76 p/Share
2,406 Added 8.66%
25,364 Class A Ordinary Share
Dec 05 2024
SELL
Open market or private sale
$23,863 $21.25 p/Share
1,123 Reduced 4.66%
22,958 Class A Ordinary Share
Dec 05 2024
BUY
Exercise of conversion of derivative security
$12,083 $10.76 p/Share
1,123 Added 4.46%
24,081 Class A Ordinary Share
Dec 04 2024
SELL
Open market or private sale
$106,760 $21.25 p/Share
5,024 Reduced 17.95%
22,958 Class A Ordinary Share
Dec 04 2024
BUY
Exercise of conversion of derivative security
$54,058 $10.76 p/Share
5,024 Added 15.22%
27,982 Class A Ordinary Share
Dec 03 2024
SELL
Open market or private sale
$192,385 $21.45 p/Share
8,969 Reduced 28.09%
22,958 Class A Ordinary Share
Dec 03 2024
BUY
Exercise of conversion of derivative security
$96,506 $10.76 p/Share
8,969 Added 21.93%
31,927 Class A Ordinary Share
Sep 02 2024
SELL
Payment of exercise price or tax liability
$25,563 $26.74 p/Share
956 Reduced 4.0%
22,958 Class A Ordinary Share
MR

Mark Ragosa

CHIEF FINANCIAL OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA